Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/1993
03/30/1993CA1315222C Polynucleotide probes and a method for their preparation
03/24/1993EP0532878A2 Process for producing acyclic nucleosides
03/24/1993EP0510085A4 Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
03/24/1993CN1070191A 1,3-oxathiolane nucleoside analogues
03/23/1993US5196402 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant
03/23/1993CA1314875C Therapeutic nucleosides
03/18/1993WO1993005163A1 Method for the selection of genetically transformed cells and compounds for use in the method
03/18/1993WO1993005059A1 Imidazolidyl macrolides
03/18/1993WO1993005058A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroarylmacrolides
03/18/1993WO1993005042A1 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
03/18/1993WO1993004680A1 Macrocyclic immunomodulators
03/17/1993EP0532089A1 N-heteroaryl, N-alkylheteroaryl, N-alkenylheteroaryl & N-alkynylheteroarylmacrolides
03/17/1993EP0532088A1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides
03/17/1993EP0531452A1 Synthesis of glycerol di- and triphosphate derivatives
03/17/1993CN1020114C Preparation for macrolide compounds
03/17/1993CN1020107C Process for antivirotic compound
03/17/1993CN1020106C Process for pyrimidine derivatives
03/16/1993US5194654 Viricides for retroviral infections such as aids
03/16/1993US5194599 Hydrogen phosphonodithioate compositions
03/16/1993CA1314503C Detectable molecules, method of preparation and use
03/10/1993EP0530901A1 13-beta-O-methoxymethyl-22,23-dihydro avermectin B1A/B1B aglycone
03/10/1993EP0530888A1 Fluoromacrolides having immunosuppressive activity
03/10/1993EP0530614A1 Novel antisense oligonucleotider with continuous phosphoramidate internucleotide linkage
03/10/1993EP0530407A1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
03/10/1993CA2077638A1 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n- alkynylheteroarylmacrolides having immunosuppressive activity
03/10/1993CA2077331A1 O-heteroaryl, o-alkylheteroaryl, o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosuppressive activity
03/09/1993US5192777 Macrolide compounds
03/09/1993US5192764 Pyrazinone n-oxide nucleosides and analogs thereof
03/09/1993US5192749 4'-substituted nucleosides
03/09/1993US5192671 Fermentation with Saccharopolyspora
03/09/1993CA1314245C Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
03/06/1993WO1993004679A1 Macrocyclic immunomodulators
03/06/1993CA2103453A1 Macrocyclic immunomodulators
03/05/1993CA2077466A1 Substituted nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
03/05/1993CA2077131A1 13beta-o-methoxymethyl-22,23-dihydro avermectin b1a-b1b aglycone as a superior antiparasitic agent
03/05/1993CA2050664A1 Antitumor aldophosphamide analogs
03/04/1993WO1993003736A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation
03/04/1993WO1993003734A1 Method for lowering blood lipid levels
03/04/1993WO1993003733A1 Syntheses, pharmaceutical composition and method of application of (2'-5') oligoadenylate analogues
03/04/1993CA2115675A1 Method for lowering blood lipid levels
03/04/1993CA2077314A1 Antisense oligonucleotides with phosphoramidate internucleotide linkage throughout
03/03/1993EP0530129A1 Method for the selection of genetically transformed cells and compounds for use in the method
03/03/1993EP0528870A1 Protein-nucleic acid probes and immunoassays using same
03/02/1993US5190950 Antagonists of immunosuppressive macrolides
03/02/1993US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes
03/02/1993US5190926 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
02/1993
02/24/1993EP0528030A1 Antitumor be-13793c derivative
02/24/1993EP0527917A1 Use of adenosine and adenosine derivatives for anesthesia
02/23/1993US5189042 Fluoromacrolides having immunosuppressive activity
02/23/1993US5189027 Hypotensive agent, vasoconstriction
02/23/1993US5188944 Process for the glycosylation of avermectin agylcones
02/23/1993CA2076419A1 Fluoromacrolides having immunosuppressive activity
02/23/1993CA1313866C 2'-deoxy-5-fluorouridine derivatives
02/18/1993WO1993003051A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
02/18/1993WO1993003048A1 Process for purifying pentostatin
02/18/1993WO1993003038A1 Novel cholesterol lowering compound
02/18/1993WO1993003027A1 1,3-oxathiolane nucleoside analogues
02/18/1993WO1993002703A1 Prodrugs activated by targeted catalytic proteins
02/18/1993WO1993002683A1 Composition for curing proliferative skin diseases
02/18/1993CA2114934A1 Prodrugs activated by targeted catalytic proteins
02/18/1993CA2113902A1 Novel cholesterol lowering compound
02/17/1993EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use
02/16/1993US5187266 Antitumor aldophosphamide glycoside and dideoxyuridine derivatives
02/16/1993US5187163 Anti-viral compounds, dosage forms and methods
02/16/1993CA1313661C 2'-deoxy-5-fluorouridine derivatives
02/10/1993EP0526935A1 New microorganism for producing C-31 desmethyl FR-900520 cyclic hemiketal
02/10/1993EP0526934A1 New C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
02/10/1993EP0526866A1 The use of adenosine compounds for the preparation in the treatment of ischaemia
02/09/1993US5185456 Macrolide compounds
02/09/1993US5185437 Therapeutic nucleosides
02/09/1993CA1313498C 3'-azido-2', 3'-dideoxyuridine anti-retroviral composition
02/08/1993CA2075543A1 Use of adenosine compounds in the treatment of ischaemia
02/08/1993CA2067540A1 Rapamycin analog as immunosuppressants and antifungals
02/04/1993WO1993002091A1 Monosaccharide analog-based glycosidase inhibitors
02/04/1993WO1993002082A1 Cyclic ketal derivatives
02/04/1993WO1992020336A3 Novel cholesterol lowering compounds
02/04/1993DE4215738A1 Novel microorganism Streptomyces albus R2374 - is e.g 5-0-sulphamoyl-2-chloro adenosine which can be used as a herbicide
02/03/1993EP0526253A1 1,3-Oxathiolane nucleoside analogues
02/03/1993EP0525479A1 Spicamycin derivatives and the use thereof
02/03/1993EP0525106A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
02/03/1993EP0524997A1 2'-o-alkyl nucleotides and polymers containing them.
02/03/1993CN1068574A Atp analogues
02/02/1993US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
02/02/1993US5183749 One step fermentation for carrying out hydroxylation or epoxidation or both reactions
02/02/1993CA2074861A1 Microorganism for producing c-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent
02/02/1993CA2074856A1 C-31 desmethyl fr-900520 cyclic hemiketal immunosuppressant agent
01/1993
01/27/1993EP0524687A1 A process for the glycosylation of avermectin compounds at the 14a-position
01/27/1993EP0524686A1 A process for the 14a-hydroxylation of avermectin compounds
01/27/1993EP0524677A1 Cyclic ketal derivatives
01/26/1993US5182207 Strains of streptomyces thermoarchaensis
01/26/1993CA1313155C Antibiotic compounds and their preparation
01/24/1993CA2074328A1 Process for the 14a-hydroxylation of avermectin compounds
01/24/1993CA2074327A1 Process for the glycosylation of avermectin compounds at the 14a-position
01/21/1993WO1993001204A1 Method and compounds for rna synthesis
01/21/1993WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
01/21/1993WO1993000910A1 Antiviral liponucleosides: treatment of hepatitis b
01/21/1993DE4223438A1 Cyclische oligonucleotidphosphorthioate Cyclic oligonucleotidphosphorthioate
01/21/1993CA2112803A1 Antiviral liponucleosides: treatment of hepatitis b
01/20/1993EP0523110A1 Nucleoside derivatives
01/20/1993CN1068111A Derivatives of (hetero) aromatic ethers and thioethers process for preparing same and pharmaceutical composition containing them